Bicalutamide is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Major Pharmaceuticals. The primary component is Bicalutamide.
Product ID | 0904-6019_78472a98-e573-47a6-bb12-02621c019ff2 |
NDC | 0904-6019 |
Product Type | Human Prescription Drug |
Proprietary Name | Bicalutamide |
Generic Name | Bicalutamide |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2010-05-11 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA078917 |
Labeler Name | Major Pharmaceuticals |
Substance Name | BICALUTAMIDE |
Active Ingredient Strength | 50 mg/1 |
Pharm Classes | Androgen Receptor Antagonists [MoA],Androgen Receptor Inhibitor [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2010-05-11 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA078917 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2010-05-11 |
Ingredient | Strength |
---|---|
BICALUTAMIDE | 50 mg/1 |
SPL SET ID: | 82d4877e-6ebf-4f75-a108-28dc840b07fc |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0093-0220 | Bicalutamide | Bicalutamide |
0904-6019 | Bicalutamide | Bicalutamide |
16714-571 | Bicalutamide | bicalutamide |
16714-816 | Bicalutamide | Bicalutamide |
16729-023 | Bicalutamide | Bicalutamide |
47335-485 | bicalutamide | bicalutamide |
60429-177 | Bicalutamide | Bicalutamide |
60505-2642 | Bicalutamide | Bicalutamide |
62559-890 | Bicalutamide | Bicalutamide |
63629-8308 | Bicalutamide | Bicalutamide |
63672-0005 | Bicalutamide | Bicalutamide |
65841-613 | Bicalutamide | Bicalutamide |
67253-191 | bicalutamide | bicalutamide |
68382-224 | Bicalutamide | Bicalutamide |
70518-2993 | Bicalutamide | Bicalutamide |
71205-577 | Bicalutamide | Bicalutamide |
71335-0765 | Bicalutamide | Bicalutamide |
0310-0705 | CASODEX | Bicalutamide |
62559-680 | CASODEX | Bicalutamide |